A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the “on-demand” scheme of administration at French autologous hematopoietic stem cell transplant programs
Chabannon, Christian, Bijou, Fontanet, Miclea, Jean-Michel, Milpied, Noel, Grouin, Jean-Marie, Mohty, MohamadVolume:
55
Language:
english
Journal:
Transfusion
DOI:
10.1111/trf.13141
Date:
September, 2015
File:
PDF, 119 KB
english, 2015